At Fornia BioSolutions, we target next generation microbial and enzyme products that have an established market, as well as novel products that will pioneer new markets. Enzyme products developed by Fornia are being used as sustainable solutions to provide alternatives for environmentally unsafe chemical processes. Moreover, the developed products are highly efficient, cost-effective, and do not require extreme temperatures or pressures to work, which saves energy and reduces greenhouse gas emissions.
Fornia’s EuphoticTM (Artificial Intelligence Guided Bioproduct Development) framework has highly collaborative domains, essential for bioproduct development, including: AI guided enzyme and microbe discovery, enzyme directed evolution, strain development, HTP selection of process relevant leads, and process-oriented validation. We acquire leading-edge AI enabling technologies to address the bottleneck issues in our bio-industrial product development. Our product patent portfolio includes 41 granted patents and 14 patent applications in US, China and Europe (including England, France, German, Spain and Romania).
Each domain is equipped with state-of-the-art equipment and teamed by seasoned research professionals with over 10 years of relevant experience, as well as talented junior researchers, with a strong passion for excellence.
Fornia’s EuphoticTM Platform
We develop our bioproducts through a unique AI-guided process.
Mutagenesis & Genetic Engineering
We apply mutagenesis strategies to improve microbial strains and genetically engineer microbes for large-scale production.
Automated & Intelligent Screening
Our automation platform facilitates accurate, reliable, and reproducible results for creating the best microbial strains.
Large Scale Fermentation
Our step-wise process ensures a high rate of success when scaling up to commercial level microbial fermentation.